Influenza, Human: all 2,264 studies

Page 2 of 23. Open to participants first (173), then studies with results posted, then the rest; newest registration first within each.

• Phase III Clinical Trial of Quadrivalent Influenza Virus Split VaccineNot yet recruitingNCT06800950Phase 3
• Oseltamivir and Baloxavir Marboxil for Prophylaxis Against Influenza Under a Hospital-based SettingNot yet recruitingNCT06762587Not applicable
• A/Texas Flu ChallengeRecruitingNCT06753474Phase 1
• Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.Not yet recruitingNCT06694025
• The Effects of Endotracheal Suctioning on Pain and Serum MarkersRecruitingNCT06692400Not applicable
• Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)RecruitingNCT06684379Phase 1/2
• Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted VaccinesRecruitingNCT06676644Not applicable
• A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic PatientsRecruitingNCT06672692Not applicable
• Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus InfectionRecruitingNCT06667063
• Vaccine Chatbot for Improving Influenza Vaccination UptakeNot yet recruitingNCT06657573Not applicable
• Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)RecruitingNCT06653569Phase 3
• Nosocomial Respiratory Virus InfectionRecruitingNCT06643039Not applicable
• Impact Of Kidney Failure On The Regulation Of Humoral Response To VaccinationRecruitingNCT06635525
• GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuERecruitingNCT06620185Not applicable
• COVID-19 Booster and IIV Schedule in Immunocompromised HostsRecruitingNCT06599658Phase 2
• Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against InfluenzaRecruitingNCT06574503Phase 3
• Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza ComplicationsRecruitingNCT06573008Phase 3
• Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe InfluenzaRecruitingNCT06528444Phase 3
• Effectiveness of SMS Nudging to Increase Coverage of Influenza Vaccination Among the ElderlyNot yet recruitingNCT06486766Not applicable
• Influenza Vaccine Effectiveness in Among Young Children in TaiwanRecruitingNCT06446232
• Dime La VerDAD: Verify, Debunk, and DisseminateRecruitingNCT06417762Not applicable
• Age Related Differences in Respiratory Immune Responses in Influenza Virus InfectionEnrolling by invitationNCT06401720
• Covid-19 and Influenza Oral Vaccine StudyRecruitingNCT06355232Phase 1
• Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsERecruitingNCT06336317Phase 4
• Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral InfectionsRecruitingNCT06315400Phase 4
• Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza VaccineRecruitingNCT06280144Phase 4
• Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.RecruitingNCT06259487Not applicable
• Dose, Safety, and Pathogenicity of a New Influenza B StrainRecruitingNCT06254820Phase 2
• The Role of Cxcr4Hi neutrOPhils in InflueNzaRecruitingNCT06254313
• A Prospective, Multicenter, Randomized Controlled Clinical Study on the Efficacy and Safety of Xuanfei Baidu Granule in the Treatment of Influenza ARecruitingNCT06205641Not applicable
• Clinical Performance Study for EDAN's COVID-19/Flu A/Flu B/RSV Test Kits on Subjects Suspected of Respiratory InfectionRecruitingNCT06175611
• Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like DiseaseNot yet recruitingNCT06175468Phase 3
• Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in IndiaRecruitingNCT06168019
• Clinical Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)RecruitingNCT06160128
• Impact on Influenza Vaccination Rates of a Telephone Text Message Recall From the Attending PhysicianRecruitingNCT06123936Not applicable
• A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household ContactsRecruitingNCT06094010Phase 3
• Intradermal Influenza VaccinationRecruitingNCT06067555Early Phase 1
• Effect of Health Education on Promoting Influenza Vaccination Health LiteracyRecruitingNCT06048406Not applicable
• H7HLAII DNA Influenza VaccineRecruitingNCT06046092Phase 1
• Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 YearsRecruitingNCT06029933
• Cost-effectiveness of the Influenza VaccinationRecruitingNCT05996549Phase 4
• High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) RecipientsRecruitingNCT05947071Phase 2
• Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro DiagnosticsNot yet recruitingNCT05946538Not applicable
• FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation ProtocolNot yet recruitingNCT05928507
• The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination ProgramRecruitingNCT05832307Not applicable
• Zoonotic Influenza Surveillance in BelgiumEnrolling by invitationNCT05827601
• Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in ChildrenRecruitingNCT05739474Phase 3
• MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme MalignanciesRecruitingNCT05735717Phase 2
• InfluenCEF Study: Study on the Headache Associated With Influenza InfectionRecruitingNCT05704335
• A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic InfluenzaRecruitingNCT05648448Phase 2
• Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental OxygenRecruitingNCT05624450Phase 3
• Bone Marrow and Peripheral Blood Immune Responses StudyRecruitingNCT05616546Phase 4
• Enhancing Protection Against Influenza and COVID-19 for Pregnant Women and Medically at Risk ChildrenRecruitingNCT05613751Not applicable
• Snack Foods and Their Impact on the Immune Response Following Influenza VaccinationRecruitingNCT05515263Not applicable
• Influenza Human Challenge ModelRecruitingNCT05332899Phase 1
• Respiratory Virus Sampling and RepositoryRecruitingNCT05266222
• Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy AdultsRecruitingNCT05108818Phase 4
• Antibiotic Therapy in Viral Airway InfectionsRecruitingNCT05045612Phase 4
• Observational Digital Biomarker Discovery in Respiratory Virus Challenge StudiesRecruitingNCT04772170
• Baloxavir and Oseltamivir for the Treatment of Severe Influenza Infection in Immunocompromised PatientsRecruitingNCT04712539Phase 2
• Understanding Immunity to the Flu Vaccine in COVID-19 PatientsRecruitingNCT04579588
• Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 InfectionRecruitingNCT04367883
• Evaluating AVM0703 for Treatment of COVID-19 or Influenza-mediated ARDSNot yet recruitingNCT04366115Phase 1
• The DETECT(Digital Engagement & Tracking for Early Control, & Treatment) StudyRecruitingNCT04336020
• Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and PneumoniaRecruitingNCT03900988Phase 3
• Influenza Associated Aspergillosis In-depth InvestigationRecruitingNCT03748069
• Immune Responses in Health Care PersonnelRecruitingNCT03323112
• Volatiles in Breath and Headspace Analysis - Diagnostic MarkersEnrolling by invitationNCT03228095
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired PneumoniaRecruitingNCT02735707Phase 3
• Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza ChallengeEnrolling by invitationNCT02511002
• Influenza Immunization in Adults Over Age 75RecruitingNCT02200276Not applicable
• Study to Investigate the Efficacy and Safety of Apomivir®Not yet recruitingNCT01677689Phase 2
• Screening for LID Clinical Studies Unit Healthy Volunteer ProtocolsRecruitingNCT01386424
• Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral InfectionTerminatedNCT06999603Phase 2Results posted
• Immunogenicity of COVID-19 Vaccine Co-administration With Influenza Vaccine in Healthy VolunteersCompletedNCT06831786Early Phase 1Results posted
• Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Chinese Pediatric Participants 1 to <12 Years of Age With Influenza SymptomsCompletedNCT06774859Phase 3Results posted
• A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy PeopleCompletedNCT06683352Phase 1/2Results posted
• Behavioral Economics to Improve Flu Vaccination Using EHR Nudges ReplicationCompletedNCT06626321Not applicableResults posted
• Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge StrainCompletedNCT06613737Not applicableResults posted
• Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in AdultsCompletedNCT06602531Phase 1/2Results posted
• A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of AgeCompletedNCT06602024Phase 3Results posted
• Characterizing Late-season Influenza Vaccine Responses to Compare the 2023 and 2024 Vaccine FormulationsCompletedNCT06567860Phase 4Results posted
• Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59CompletedNCT06560151Phase 2Results posted
• Immunogenicity of Influenza VaccinationsCompletedNCT06518577Phase 4Results posted
• A Clinical Study to Investigate the Safety and Immunogenicity in Relation to Product Attributes of mRNA-1083 (Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] and Influenza Vaccine)CompletedNCT06508320Phase 2Results posted
• Revealing Protective Immunity to Influenza Using Systems ImmunologyCompletedNCT06501963Phase 4Results posted
• A Study About Modified RNA Vaccines Against Influenza in Healthy AdultsCompletedNCT06436703Phase 1/2Results posted
• A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older AdultsCompletedNCT06431607Phase 2Results posted
• A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and AboveCompletedNCT06361875Phase 1/2Results posted
• Digital Storytelling to Reduce Pediatric Influenza Vaccination DisparitiesTerminatedNCT06274359Not applicableResults posted
• A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy AdultsCompletedNCT06237049Phase 2Results posted
• Evaluation of a Screen and Treat Protocol for InfluenzaTerminatedNCT06207058Results posted
• CX-4945 in Viral Community Acquired PneumoniaTerminatedNCT06202521Phase 2Results posted
• SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory SettingsCompletedNCT06191393Not applicableResults posted
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.CompletedNCT06178991Phase 3Results posted
• Performance Evaluation of the Lucira COVID-19 & Flu TestCompletedNCT06141824Not applicableResults posted
• A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of AgeCompletedNCT06097273Phase 3Results posted
• Patient Portal Flu Vaccine Reminders (RCT 6)CompletedNCT06062264Not applicableResults posted
• Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCPCompletedNCT06054269Phase 3Results posted
• Systems Biological Assessment of Statin Effect on Vaccine ResponsesCompletedNCT06024096Phase 4Results posted

← Influenza, Human overview